Register before next rate increase

Partner with the Leaders Building Medtech

March 17th - 21st | Waldorf Astoria, Monarch Beach |
Dana Point, CA
Secure Your Spot arrow Hotel Almost Full

Apply to Present   icon

On-stage presentation to a full house of investors

Apply to Exhibit   icon

Private demo and partnering space in our Innovator Pavilion

Sponsorship Opportunities   icon

Elevate your brand at the epicenter of the industry

Trusted By The Companies Pioneering What’s Next

the Ethos of our events
World-class executives, convening in world-class venues to do real business

In 2024, LSI USA convened 1,500 executives from emerging companies, venture capital and private equity firms, family offices, global strategics, professional service providers, and more.

LSI USA will never be held in a chaotic convention center. It is a curated forum where real business gets done, hosted in world-class venues where senior executives want to do business.

Speakers and Attendees

Industry-leading executives from emerging companies, venture capital and private equity firms, family offices, investment banks, global strategics, and more.

View all Attendees
Celine Martin

Company Group Chairman, Cardiovascular & Specialty Solutions Group

Johnson & Johnson

Jay Watkins

Co-Chair and Partner

Sonder Capital

Lisa Earnhardt

Executive Vice President and Group President

Abbott

Paul LaViolette

Managing Partner & Chief Operating Officer

SV Health Investors

Murielle Thinard McLane

Director

Intuitive Ventures

John Ryan

Managing Director

Wells Fargo Strategic Capital

Greg Madden

Managing Partner

SV Health Investors

Chris Eso

Vice President, Business Development, Strategy & Portfolio Management for the Cardiovascular Portfolio

Medtronic

Present at LSI USA ‘25
LSI USA ‘25
Presenting Companies

Present to a full house of investors and strategics alongside the CEOs and Founders building technology that is shaping the future of healthcare.

  • Portal Instruments

    Presenter

    arrow
    Patrick Anquetil

    CEO

    Portal Instruments is developing a needle-free technology for the delivery of biologics. The handheld device is capable of delivering small and large molecules through subcutaneous, intradermal and intramuscular tissue layers. Portal's technology will improve the patient experience, providing greater comfort during drug administration. Visit website.

    Portal Instruments

    Presenter

    arrow
    Patrick Anquetil

    CEO

    Portal Instruments is developing a needle-free technology for the delivery of biologics. The handheld device is capable of delivering small and large molecules through subcutaneous, intradermal and intramuscular tissue layers. Portal's technology will improve the patient experience, providing greater comfort during drug administration. Visit website.

    Isola Therapeutics

    Presenter

    Isola Therapeutics is committed to developing more effective and accessible treatments to address the increasing burden of cancer. The company is developing a local drug delivery system that delivers chemotherapeutic payloads to solid tumors, while reducing systemic complications often associated with traditional chemotherapy regimens.  Visit website.

    Isola Therapeutics

    Presenter

    Isola Therapeutics is committed to developing more effective and accessible treatments to address the increasing burden of cancer. The company is developing a local drug delivery system that delivers chemotherapeutic payloads to solid tumors, while reducing systemic complications often associated with traditional chemotherapy regimens.  Visit website.

    Navigation Sciences

    Presenter

    arrow
    Alan Lucas

    CEO

    Navigation Sciences™ is a clinical-stage company developing the NaviSci™ System for the tissue conserving removal of lung cancer and other soft tissue tumors. The system integrates Augmented Reality (AR) and advanced software with surgical hardware to guide precise surgical resection by enabling for the first time, real-time in-vivo margin measurement. Visit website.

    Navigation Sciences

    Presenter

    arrow
    Alan Lucas

    CEO

    Navigation Sciences™ is a clinical-stage company developing the NaviSci™ System for the tissue conserving removal of lung cancer and other soft tissue tumors. The system integrates Augmented Reality (AR) and advanced software with surgical hardware to guide precise surgical resection by enabling for the first time, real-time in-vivo margin measurement. Visit website.

    Bionic Vision Technologies

    Presenter

    arrow
    Ash Attia

    CEO

    BVT Bionic Eye System is a suprachoroidal visual implant that has been designed to restore functional vision to the blind suffering from inherited retinal diseases. The Bionic Eye System consists of a retinal implant that receives visual images that are captured, processed, and transferred via a wearable device and processing unit.  Visit website.

    Bionic Vision Technologies

    Presenter

    arrow
    Ash Attia

    CEO

    BVT Bionic Eye System is a suprachoroidal visual implant that has been designed to restore functional vision to the blind suffering from inherited retinal diseases. The Bionic Eye System consists of a retinal implant that receives visual images that are captured, processed, and transferred via a wearable device and processing unit.  Visit website.

    SentiAR

    Presenter

    arrow
    Berk Tas

    CEO

    Transforming the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient. Visit website.

    SentiAR

    Presenter

    arrow
    Berk Tas

    CEO

    Transforming the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient. Visit website.

    LEM Surgical

    Presenter

    arrow
    Yossi Bar

    CEO

    LEM Surgical is focused on creating and providing the next generation of robotic surgical systems. The company's flagship product, the Dynamis System, is a multi-arm robotic surgical system that incorporates novel navigation capabilities and has an open architecture for handling concentric tools. Dynamis is intended to be a platform technology for orthopedic and neurosurgical applications. Visit website.

    LEM Surgical

    Presenter

    arrow
    Yossi Bar

    CEO

    LEM Surgical is focused on creating and providing the next generation of robotic surgical systems. The company's flagship product, the Dynamis System, is a multi-arm robotic surgical system that incorporates novel navigation capabilities and has an open architecture for handling concentric tools. Dynamis is intended to be a platform technology for orthopedic and neurosurgical applications. Visit website.

    Field Orthopaedics

    Presenter

    arrow
    Patryk Kania

    CEO and President

    Field Orthopaedics is dedicated to developing innovative products to meet the needs of complex fracture management, arthritis and microsurgery. The company's portfolio of cannulated screws and intramedullary nailing system address the challenges critical to advancing hand surgery. Visit website.

    Field Orthopaedics

    Presenter

    arrow
    Patryk Kania

    CEO and President

    Field Orthopaedics is dedicated to developing innovative products to meet the needs of complex fracture management, arthritis and microsurgery. The company's portfolio of cannulated screws and intramedullary nailing system address the challenges critical to advancing hand surgery. Visit website.

    Juniper Biomedical

    Presenter

    arrow
    David Constantine

    CEO

    Juniper Biomedical is developing a precision neuromodulation micro-implant to treat pelvic health conditions. Visit website.

    Juniper Biomedical

    Presenter

    arrow
    David Constantine

    CEO

    Juniper Biomedical is developing a precision neuromodulation micro-implant to treat pelvic health conditions. Visit website.

    Ossiform

    Presenter

    arrow
    Thea Wulff Olesen

    CEO

    Ossiform is the developer of fully resorbable patient-matched implants, tailored to improve bone healing outcomes in orthopedics and spine. According to Ossiform: We Print Bone™. Visit website.

    Ossiform

    Presenter

    arrow
    Thea Wulff Olesen

    CEO

    Ossiform is the developer of fully resorbable patient-matched implants, tailored to improve bone healing outcomes in orthopedics and spine. According to Ossiform: We Print Bone™. Visit website.

    Runway Healthcare

    Presenter

    arrow
    Jeffrey O'Donnell, Jr.

    CEO

    Runway Healthcare is a medical device venture studio helping bring innovative, early-stage technologies to market in partnership with entrepreneurial doctors, professionals, and businesses. The company's portfolio currently consists of multiple orthopedic-focused businesses dedicated to enabling physicians and improving patient care. Visit website.

    Runway Healthcare

    Presenter

    arrow
    Jeffrey O'Donnell, Jr.

    CEO

    Runway Healthcare is a medical device venture studio helping bring innovative, early-stage technologies to market in partnership with entrepreneurial doctors, professionals, and businesses. The company's portfolio currently consists of multiple orthopedic-focused businesses dedicated to enabling physicians and improving patient care. Visit website.

    CDX Medical Technologies

    Presenter

    arrow
    Gopal K. Chopra

    Co-CEO

    CDX is a compact portable extracorporeal bypass pump for partial cardio-pulmonary support, adaptable to multiple circuit configurations including oxygenators. CDX's technology is an innovative, light-weight support system with multiple power options. The CDX pump platform is a disposable cartridge combined with a re-useable controller and stator. The entire system is less than 6 pounds in weight and can be primed and ready to support in less than 2 minutes. visit website

    CDX Medical Technologies

    Presenter

    arrow
    Gopal K. Chopra

    Co-CEO

    CDX is a compact portable extracorporeal bypass pump for partial cardio-pulmonary support, adaptable to multiple circuit configurations including oxygenators. CDX's technology is an innovative, light-weight support system with multiple power options. The CDX pump platform is a disposable cartridge combined with a re-useable controller and stator. The entire system is less than 6 pounds in weight and can be primed and ready to support in less than 2 minutes. visit website

    Novian Health

    Presenter

    arrow
    Henry (Chip) Appelbaum

    President & CEO

    Novian Health has developed a laser-based system for the treatment of tumors. The technology is intended to be a minimally invasive alternative to surgery in select cancerous and non-cancerous tumors. Novian has received the CE Mark for the treatment of malignant and benign breast tumors. The company's Novilase technology is currently cleared in the US for the treatment of benign breast tumors and soft tissue ablation. Visit website.

    Novian Health

    Presenter

    arrow
    Henry (Chip) Appelbaum

    President & CEO

    Novian Health has developed a laser-based system for the treatment of tumors. The technology is intended to be a minimally invasive alternative to surgery in select cancerous and non-cancerous tumors. Novian has received the CE Mark for the treatment of malignant and benign breast tumors. The company's Novilase technology is currently cleared in the US for the treatment of benign breast tumors and soft tissue ablation. Visit website.

  • SamanTree Medical

    Presenter

    arrow
    Olivier Delporte

    CEO

    SamanTree Medical's Histolog Scanner is a digital microscopy scanner for high-resolution imaging of the surface of fresh tissue. The device utilizes novel, ultra-fast confocal microscopy technology to enable rapid histological assessment in the operating room or pathology laboratory.  Visit website.

    SamanTree Medical

    Presenter

    arrow
    Olivier Delporte

    CEO

    SamanTree Medical's Histolog Scanner is a digital microscopy scanner for high-resolution imaging of the surface of fresh tissue. The device utilizes novel, ultra-fast confocal microscopy technology to enable rapid histological assessment in the operating room or pathology laboratory.  Visit website.

    Agada Medical

    Presenter

    arrow
    Scott Gunnigle

    CEO

    Agada Medical is innovating in the field of spine surgery through their development of an Enterprise AI system named THE SPINE ORACLE™. This system aims to revolutionize spine surgery planning by using anthropometric, demographic, diagnostic data, and biomechanical models to predict surgical outcomes and costs. It leverages AI to analyze spine motion, surgical simulations and force distributions, offering prescriptive and predictive analytics to reduce unnecessary surgeries by comparing various surgical options. Visit website.

    Agada Medical

    Presenter

    arrow
    Scott Gunnigle

    CEO

    Agada Medical is innovating in the field of spine surgery through their development of an Enterprise AI system named THE SPINE ORACLE™. This system aims to revolutionize spine surgery planning by using anthropometric, demographic, diagnostic data, and biomechanical models to predict surgical outcomes and costs. It leverages AI to analyze spine motion, surgical simulations and force distributions, offering prescriptive and predictive analytics to reduce unnecessary surgeries by comparing various surgical options. Visit website.

    Brain4Care

    Presenter

    arrow
    Carlos Bremer

    President North American Division

    Brain4care offers an FDA-cleared and non-invasive Intracranial Pressure (ICP) dynamics monitoring technology, eliminating the invasiveness of the current gold standard and unlocking its applicability for patients with brain damage, beyond the ICU. By breaking down the barriers to accessibility and expanding its utility by using an AI platform, the company aims to make ICP monitoring a routine and essential part of patient care anytime and anywhere. Visit website.

    Brain4Care

    Presenter

    arrow
    Carlos Bremer

    President North American Division

    Brain4care offers an FDA-cleared and non-invasive Intracranial Pressure (ICP) dynamics monitoring technology, eliminating the invasiveness of the current gold standard and unlocking its applicability for patients with brain damage, beyond the ICU. By breaking down the barriers to accessibility and expanding its utility by using an AI platform, the company aims to make ICP monitoring a routine and essential part of patient care anytime and anywhere. Visit website.

    Spiro Roboitcs

    Presenter

    arrow
    Dimitri Sokolov

    CEO

    Spiro Robotics is developing an innovative handheld robot intended to automate airway management in patients requiring tracheal intubation.  Visit website.

    Spiro Roboitcs

    Presenter

    arrow
    Dimitri Sokolov

    CEO

    Spiro Robotics is developing an innovative handheld robot intended to automate airway management in patients requiring tracheal intubation.  Visit website.

    Adaptyx Biosceinces

    Presenter

    arrow
    Vijit Sabnis

    Co-Founder

    Adaptyx Biosciences, a Stanford University spin-off, is building a biomonitoring platform that leverages 15 years of research in molecular switches and microarray patches, enabling minimally-invasive real-time, continuous sensing of small molecules and proteins. Adaptyx's library of multi-analyte sensors will enable deeply personalized medicine across drug dosing, hormone regulation, kidney health, cardiovascular disease, and oncology.

    Adaptyx Biosceinces

    Presenter

    arrow
    Vijit Sabnis

    Co-Founder

    Adaptyx Biosciences, a Stanford University spin-off, is building a biomonitoring platform that leverages 15 years of research in molecular switches and microarray patches, enabling minimally-invasive real-time, continuous sensing of small molecules and proteins. Adaptyx's library of multi-analyte sensors will enable deeply personalized medicine across drug dosing, hormone regulation, kidney health, cardiovascular disease, and oncology.

    Alara Med

    Presenter

    arrow
    Mark Salley

    CEO

    The cumulative exposure to ionizing radiation during medical procedures poses serious health risks to patients, surgical staff, and surgeons. AlaraMed is rethinking radiation safety with a portfolio of products designed to reduce unnecessary radiation exposure. The company’s lead product is a device for endoscopic kidney surgery and other fluoroscopy procedures that reduces fluoroscopy time by ~80%.  Visit website.

    Alara Med

    Presenter

    arrow
    Mark Salley

    CEO

    The cumulative exposure to ionizing radiation during medical procedures poses serious health risks to patients, surgical staff, and surgeons. AlaraMed is rethinking radiation safety with a portfolio of products designed to reduce unnecessary radiation exposure. The company’s lead product is a device for endoscopic kidney surgery and other fluoroscopy procedures that reduces fluoroscopy time by ~80%.  Visit website.

    Aulisa Medical

    Presenter

    arrow
    Augustine Lien

    CEO

    Aulisa specializes in the development and commercialization of wearable solutions for continuous remote monitoring of patient vitals. The company's proprietary technology continuously monitors vital signs to identify health incidents prior to them occurring. Rapid spot-checking of patient vitals allows the device to alert providers and parents to health incidents, expanding the window in which appropriate treatment and care can be delivered. The company's flagship product, the Guardian Angel RX system, has been adapted for use in infants, children, and adults. Visit website.

    Aulisa Medical

    Presenter

    arrow
    Augustine Lien

    CEO

    Aulisa specializes in the development and commercialization of wearable solutions for continuous remote monitoring of patient vitals. The company's proprietary technology continuously monitors vital signs to identify health incidents prior to them occurring. Rapid spot-checking of patient vitals allows the device to alert providers and parents to health incidents, expanding the window in which appropriate treatment and care can be delivered. The company's flagship product, the Guardian Angel RX system, has been adapted for use in infants, children, and adults. Visit website.

    Axena Health

    Presenter

    arrow
    Eileen Maus

    CEO

    Axena Health is dedicated to improving the lives of women with pelvic floor disorders. The company's Leva Pelvic Health system helps women train and strengthen their pelvic floor muscles from their homes to improve the management of stress, mixed, and mild-to-moderate urinary incontinence and chronic fecal incontinence.  Visit website.

    Axena Health

    Presenter

    arrow
    Eileen Maus

    CEO

    Axena Health is dedicated to improving the lives of women with pelvic floor disorders. The company's Leva Pelvic Health system helps women train and strengthen their pelvic floor muscles from their homes to improve the management of stress, mixed, and mild-to-moderate urinary incontinence and chronic fecal incontinence.  Visit website.

    Azra Care

    Presenter

    arrow
    Christian Pean

    CEO

    Azra Care is a healthcare technology company specializing in integrating SaaS AI solutions into orthopedic care to enhance patient outcomes and operational efficiency. The company’s platform leverages advanced analytics and machine learning to support evidence-based, equity-focused clinical decision-making and population health management. Azra Care is committed to transforming orthopedic surgery and care delivery through innovative, value-based approaches that address racial disparities and improve healthcare access for all. Visit website.

    Azra Care

    Presenter

    arrow
    Christian Pean

    CEO

    Azra Care is a healthcare technology company specializing in integrating SaaS AI solutions into orthopedic care to enhance patient outcomes and operational efficiency. The company’s platform leverages advanced analytics and machine learning to support evidence-based, equity-focused clinical decision-making and population health management. Azra Care is committed to transforming orthopedic surgery and care delivery through innovative, value-based approaches that address racial disparities and improve healthcare access for all. Visit website.

    Bimini Health Tech

    Presenter

    arrow
    Bradford Conlan

    CEO

    Bimini Healthtech is developing a diverse portfolio of regenerative technologies and therapeutics that enable people to live better lives. The company is commercializing and investigating autologous and allogenic products and therapies intended for use at the point-of-care to eliminate the need for matching patients with donors.  Visit website.

    Bimini Health Tech

    Presenter

    arrow
    Bradford Conlan

    CEO

    Bimini Healthtech is developing a diverse portfolio of regenerative technologies and therapeutics that enable people to live better lives. The company is commercializing and investigating autologous and allogenic products and therapies intended for use at the point-of-care to eliminate the need for matching patients with donors.  Visit website.

    CairnSurgical

    Presenter

    arrow
    David Danielsen

    CEO

    CairnSurgical is developing an innovative tool to guide surgical interventions in patients with cancer. The company's Breast Cancer Locator (BCL) is a proprietary, patient-specific, 3D printed surgical guide intended to reduce positive margins during breast cancer tumor removal. The solution uses MRI data to create a personalized model that assist surgeons in localization and excision of tumors to reduce positive margins. Visit website.

    CairnSurgical

    Presenter

    arrow
    David Danielsen

    CEO

    CairnSurgical is developing an innovative tool to guide surgical interventions in patients with cancer. The company's Breast Cancer Locator (BCL) is a proprietary, patient-specific, 3D printed surgical guide intended to reduce positive margins during breast cancer tumor removal. The solution uses MRI data to create a personalized model that assist surgeons in localization and excision of tumors to reduce positive margins. Visit website.

    Neuronoff

    Presenter

    arrow
    Manfred Franke

    CEO

    Neuronoff is developing an injectable electrode platform that is an adaptive, minimally invasive technology that transforms complex neuromodulation procedures into simple outpatient procedures. The Injectrode technology enables the electrical stimulation of hard to reach nerves and tissues using an 18 ga needle and self-anchor to prevent lead migration. Visit website.

    Neuronoff

    Presenter

    arrow
    Manfred Franke

    CEO

    Neuronoff is developing an injectable electrode platform that is an adaptive, minimally invasive technology that transforms complex neuromodulation procedures into simple outpatient procedures. The Injectrode technology enables the electrical stimulation of hard to reach nerves and tissues using an 18 ga needle and self-anchor to prevent lead migration. Visit website.

  • ConnCons

    Presenter

    arrow
    Jochen Hampe

    CEO

    ConnCons integrates connectivity into infusion consumables to create a cloud to vessel end-to-end digital solution. The system enables safer, faster and automated therapies with a superior patient experience. First clinical applications are targeted at both center-based and home oncological therapy. Visit website.

    ConnCons

    Presenter

    arrow
    Jochen Hampe

    CEO

    ConnCons integrates connectivity into infusion consumables to create a cloud to vessel end-to-end digital solution. The system enables safer, faster and automated therapies with a superior patient experience. First clinical applications are targeted at both center-based and home oncological therapy. Visit website.

    LifeSignals

    Presenter

    arrow
    Surendar Magar

    CEO

    Supporting the development of wearable microsensors for the measuresment of biometric signals. LifeSignals works with companies to develop health and wellness monitoring solutions with their portfolio of patented hardware and software. Visit website.

    LifeSignals

    Presenter

    arrow
    Surendar Magar

    CEO

    Supporting the development of wearable microsensors for the measuresment of biometric signals. LifeSignals works with companies to develop health and wellness monitoring solutions with their portfolio of patented hardware and software. Visit website.

    Linshom Medical

    Presenter

    arrow
    Richard Hughen

    CEO

    Linshom (“to breathe”) is first to deliver an Operating Room quality respiratory profile to the patient bedside and home for continuous, predictive respiratory monitoring (CPRM). Our FDA cleared device provides a full respiratory profile delivered continuously and in real time to predict and intercept respiratory decline before an emergency develops. Visit website.

    Linshom Medical

    Presenter

    arrow
    Richard Hughen

    CEO

    Linshom (“to breathe”) is first to deliver an Operating Room quality respiratory profile to the patient bedside and home for continuous, predictive respiratory monitoring (CPRM). Our FDA cleared device provides a full respiratory profile delivered continuously and in real time to predict and intercept respiratory decline before an emergency develops. Visit website.

    Medfiniti

    Presenter

    arrow
    Michael Goeree

    Founder & Chairman

    Medfiniti is focused on specialized medtech solutions to market through expertise in business strategy and M&A. It's lead portfolio company, HemWell MD, is pioneering an electrosurgical procedure for the treatment of symptomatic hemorrhoids. Performed in an outpatient setting, the device ligates hemorrhoids to provide rapid relief to patients in less.  Visit website.

    Medfiniti

    Presenter

    arrow
    Michael Goeree

    Founder & Chairman

    Medfiniti is focused on specialized medtech solutions to market through expertise in business strategy and M&A. It's lead portfolio company, HemWell MD, is pioneering an electrosurgical procedure for the treatment of symptomatic hemorrhoids. Performed in an outpatient setting, the device ligates hemorrhoids to provide rapid relief to patients in less.  Visit website.

    Neuroelectrics

    Presenter

    arrow
    Ana Maiques

    CEO

    Diagnostic and treatment telemedicine wireless platforms based on Starstim and Enobio, combining multichannel transcranial current stimulation such as tDCS with EEG. Visit website.

    Neuroelectrics

    Presenter

    arrow
    Ana Maiques

    CEO

    Diagnostic and treatment telemedicine wireless platforms based on Starstim and Enobio, combining multichannel transcranial current stimulation such as tDCS with EEG. Visit website.

    Osteal Therapeutics

    Presenter

    arrow
    David Thompson

    CEO

    Osteal Therapeutics is a musculoskeletal therapeutics company developing solutions for the treatment of orthopedic infections. The company's lead product, VT-X7, is a drug-device combination that utilizes high concentrations of vancomycin and tobramycin, in conjunction with a drug delivery system, to irrigate infected joint spaces as a result of periprosthetic joint infection in joint replacement patients.  Visit website.

    Osteal Therapeutics

    Presenter

    arrow
    David Thompson

    CEO

    Osteal Therapeutics is a musculoskeletal therapeutics company developing solutions for the treatment of orthopedic infections. The company's lead product, VT-X7, is a drug-device combination that utilizes high concentrations of vancomycin and tobramycin, in conjunction with a drug delivery system, to irrigate infected joint spaces as a result of periprosthetic joint infection in joint replacement patients.  Visit website.

    PercuSense

    Presenter

    arrow
    Brian Kannard

    Founder

    PercuSense’s continuous multi-analyte sensor system combines monitoring of multiple biosensors with knowledge of how diseases and illness progress to intelligently and proactively recommend treatment. Visit website.

    PercuSense

    Presenter

    arrow
    Brian Kannard

    Founder

    PercuSense’s continuous multi-analyte sensor system combines monitoring of multiple biosensors with knowledge of how diseases and illness progress to intelligently and proactively recommend treatment. Visit website.

    Sana Health

    Presenter

    arrow
    Richard Hanbury

    CEO

    Non-invasive bio-therapeutic device for pain management. Visit website.

    Sana Health

    Presenter

    arrow
    Richard Hanbury

    CEO

    Non-invasive bio-therapeutic device for pain management. Visit website.

    Sonofii

    Presenter

    arrow
    Roberta Lee

    CEO

    Sonofii has developed a Dynamic Dual Therapy to treat intractable soft tissue infections. The company's first clinical trial had an 80% success in curing infections that failed conventional therapy. In this multi billion dollar market, Sonofii is poised to advance treatment, improve patients’ lives and significantly reduce costs to the health care system. Visit website.

    Sonofii

    Presenter

    arrow
    Roberta Lee

    CEO

    Sonofii has developed a Dynamic Dual Therapy to treat intractable soft tissue infections. The company's first clinical trial had an 80% success in curing infections that failed conventional therapy. In this multi billion dollar market, Sonofii is poised to advance treatment, improve patients’ lives and significantly reduce costs to the health care system. Visit website.

    Arsenal Medical

    Presenter

    arrow
    Upma Sharma

    President & CEO

    Arsenal Medical develops purpose-built biomaterials to solve challenging and underserved medical problems. Our lead products target neurovascular and trauma conditions providing control of blood flow to tumors and hemorrhage.  Visit website.

    Arsenal Medical

    Presenter

    arrow
    Upma Sharma

    President & CEO

    Arsenal Medical develops purpose-built biomaterials to solve challenging and underserved medical problems. Our lead products target neurovascular and trauma conditions providing control of blood flow to tumors and hemorrhage.  Visit website.

    Vektor Medical

    Presenter

    Vektor Medical is on a mission to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias. Through its AI-based, non-invasive arrhythmia analysis technology, vMap, the company aims to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency. Visite website.

    Vektor Medical

    Presenter

    Vektor Medical is on a mission to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias. Through its AI-based, non-invasive arrhythmia analysis technology, vMap, the company aims to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency. Visite website.

    Restera

    Presenter

    arrow
    Rick O'Connor

    CEO

    Restera is developing an outpatient injectable stimulation solution for all obstructive sleep apnea (OSA) indications. The company's disruptive, injectable, dual-target stimulation solution offers immediate and unrivaled therapy. Their landmark published therapy won the 2024 best abstract award. Founded by serial entrepreneurs with multiple exits. Visit website.

    Restera

    Presenter

    arrow
    Rick O'Connor

    CEO

    Restera is developing an outpatient injectable stimulation solution for all obstructive sleep apnea (OSA) indications. The company's disruptive, injectable, dual-target stimulation solution offers immediate and unrivaled therapy. Their landmark published therapy won the 2024 best abstract award. Founded by serial entrepreneurs with multiple exits. Visit website.

  • THINK Surgical

    Presenter

    arrow
    Stuart Simpson

    CEO

    THINK Surgical develops and commercializes robotic surgery systems for the orthopedics market. The company's TSolution One is indicated for total knee arthroplasty. The system is capable of fully automated bone preparation that is personalized and prepared utilizing proprietary planning tools to achieve optimal fit of the selected knee implant. Visit website.

    THINK Surgical

    Presenter

    arrow
    Stuart Simpson

    CEO

    THINK Surgical develops and commercializes robotic surgery systems for the orthopedics market. The company's TSolution One is indicated for total knee arthroplasty. The system is capable of fully automated bone preparation that is personalized and prepared utilizing proprietary planning tools to achieve optimal fit of the selected knee implant. Visit website.

    Nutromics

    Presenter

    arrow
    Peter Vranes

    CEO

    Nutromics is pioneering Continuous Molecular Monitoring (CMM), a real-time biomarker monitoring platform that offers molecular patient data. The technology integrates into a wearable smart patch that continuously captures and transmits data to mobile and web-based applications for easy integration with hospital and consumer health software.  Visit website.

    Nutromics

    Presenter

    arrow
    Peter Vranes

    CEO

    Nutromics is pioneering Continuous Molecular Monitoring (CMM), a real-time biomarker monitoring platform that offers molecular patient data. The technology integrates into a wearable smart patch that continuously captures and transmits data to mobile and web-based applications for easy integration with hospital and consumer health software.  Visit website.

    Sparta Biomedical

    Presenter

    arrow
    Dimitrios Angelis

    Co-Founder

    The first osseointegrative biomimetic knee cartilage implant. Visit website.

    Sparta Biomedical

    Presenter

    arrow
    Dimitrios Angelis

    Co-Founder

    The first osseointegrative biomimetic knee cartilage implant. Visit website.

    Flow Medical

    Presenter

    arrow
    Jennifer Fried

    CEO

    Flow Medical is developing a novel thrombolytic catheter for the treatment of pulmonary embolism. The device will combine imaging, infusion, and monitoring into a single solution to streamline procedures, improve therapeutic efficacy, and reduce inventory needs. Visit website.

    Flow Medical

    Presenter

    arrow
    Jennifer Fried

    CEO

    Flow Medical is developing a novel thrombolytic catheter for the treatment of pulmonary embolism. The device will combine imaging, infusion, and monitoring into a single solution to streamline procedures, improve therapeutic efficacy, and reduce inventory needs. Visit website.

    PhotoniCare

    Presenter

    arrow
    Cary Vance

    CEO

    The OtoSight Middle Ear Scope enables clinicians to quickly and easily see directly through the eardrum to directly visualize the middle ear, drastically improving care for middle ear infections, the leading cause of hearing loss, antibiotic use, and surgeries in children. The novel device has new reimbursement codes that are seeing robust payment rates. Visit website.

    PhotoniCare

    Presenter

    arrow
    Cary Vance

    CEO

    The OtoSight Middle Ear Scope enables clinicians to quickly and easily see directly through the eardrum to directly visualize the middle ear, drastically improving care for middle ear infections, the leading cause of hearing loss, antibiotic use, and surgeries in children. The novel device has new reimbursement codes that are seeing robust payment rates. Visit website.

    Pulnovo Medical

    Presenter

    arrow
    Erika Chen

    Business Development Lead

    Pulnovo Medical is developing radiofrequency (RF) solutions for the treatment of pulmonary hypertension. PADN is a multipolar synchronous pulmonary artery RF ablation catheter that is intended to treat pulmonary hypertension by ablating the sympathetic nerve at the target site. The device is capable of point-to-point ablation of pulmonary sympathetic nerves. Visit website.

    Pulnovo Medical

    Presenter

    arrow
    Erika Chen

    Business Development Lead

    Pulnovo Medical is developing radiofrequency (RF) solutions for the treatment of pulmonary hypertension. PADN is a multipolar synchronous pulmonary artery RF ablation catheter that is intended to treat pulmonary hypertension by ablating the sympathetic nerve at the target site. The device is capable of point-to-point ablation of pulmonary sympathetic nerves. Visit website.

    Navigate Maternity

    Presenter

    arrow
    Ariana McGee

    Founder & Chief Executive Officer

    Navigate Maternity is a tech-enabled medical device company dedicated to improving maternal health. Their system enhances care coordination through remote monitoring, capturing key biometric data from the first prenatal appointment to twelve months postpartum via a mobile app and Bluetooth devices. The app also provides validated questionnaires for better clinical decision-making. Visit website.

    Navigate Maternity

    Presenter

    arrow
    Ariana McGee

    Founder & Chief Executive Officer

    Navigate Maternity is a tech-enabled medical device company dedicated to improving maternal health. Their system enhances care coordination through remote monitoring, capturing key biometric data from the first prenatal appointment to twelve months postpartum via a mobile app and Bluetooth devices. The app also provides validated questionnaires for better clinical decision-making. Visit website.

    EP Solutions

    Presenter

    arrow
    Marcin Golebicki

    CEO

    EP Solutions is improving clinical outcomes in cardiac resynchronization therapy cases through the use of noninvasive cardiac mapping technology. The company's Amycard 01C is an electrophysiology workstation that records body surface electrograms to create optimized 3D heart models that merge ECG data with anatomical data obtained from medical imaging. EP Solutions' technology helps physicians accurately place CRT leads during implantation and optimize devices during follow-up visits. Visit website.

    EP Solutions

    Presenter

    arrow
    Marcin Golebicki

    CEO

    EP Solutions is improving clinical outcomes in cardiac resynchronization therapy cases through the use of noninvasive cardiac mapping technology. The company's Amycard 01C is an electrophysiology workstation that records body surface electrograms to create optimized 3D heart models that merge ECG data with anatomical data obtained from medical imaging. EP Solutions' technology helps physicians accurately place CRT leads during implantation and optimize devices during follow-up visits. Visit website.

    Buck Surgical

    Presenter

    arrow
    Donald Buck

    CEO

    Buck Surgical is dedicated to addressing the challenges of gastrointestinal, microvascular, and vascular surgery with its patented coupling technology. The company has developed a novel and efficient solution that rapidly creates a connection (anastomoses) to provide unobstructed flow. Visit website.

    Buck Surgical

    Presenter

    arrow
    Donald Buck

    CEO

    Buck Surgical is dedicated to addressing the challenges of gastrointestinal, microvascular, and vascular surgery with its patented coupling technology. The company has developed a novel and efficient solution that rapidly creates a connection (anastomoses) to provide unobstructed flow. Visit website.

    Joint Preservation Innovations

    Presenter

    arrow
    Sanjeev Bhatia

    CEO

    Joint Preservation Innovations (JPI) is proud to present the Articulator Bone Resector, a novel arthroscopic articulating bone resection tool. Developed over 7 years with input from leading surgeons along with automotive, aerospace and medical device engineers, Articulator gives minimally invasive surgeons the freedom to finally articulate rotary cutting tools for bone resection in a manner never before possible. Awarded an FDA Breakthrough Device Designation in 2023, Articulator aims to reduce the surgical footprint of various musculoskeletal procedures, including large market applications in arthroscopic, endoscopic spinal and robotic surgery. Visit website.

    Joint Preservation Innovations

    Presenter

    arrow
    Sanjeev Bhatia

    CEO

    Joint Preservation Innovations (JPI) is proud to present the Articulator Bone Resector, a novel arthroscopic articulating bone resection tool. Developed over 7 years with input from leading surgeons along with automotive, aerospace and medical device engineers, Articulator gives minimally invasive surgeons the freedom to finally articulate rotary cutting tools for bone resection in a manner never before possible. Awarded an FDA Breakthrough Device Designation in 2023, Articulator aims to reduce the surgical footprint of various musculoskeletal procedures, including large market applications in arthroscopic, endoscopic spinal and robotic surgery. Visit website.

    Satisfai Health

    Presenter

    arrow
    Solveig Johannessen

    CEO

    Satisfai Health is a software company focusing on computer vision AI for gastroenterology, across both endoscopic and ultrasound imaging. Our products are used by pharmaceutical companies and healthcare providers to digitally assess important, life-altering conditions, including Inflammatory Bowel Disease and pre-Esophageal Cancer. Visit website.

    Satisfai Health

    Presenter

    arrow
    Solveig Johannessen

    CEO

    Satisfai Health is a software company focusing on computer vision AI for gastroenterology, across both endoscopic and ultrasound imaging. Our products are used by pharmaceutical companies and healthcare providers to digitally assess important, life-altering conditions, including Inflammatory Bowel Disease and pre-Esophageal Cancer. Visit website.

    CAPS Medical

    Presenter

    arrow
    Ilan Uchitel

    CEO & Co-Founder

    CAPS Medical is developing a solution to treat a wide range of solid tumors using Non-thermal Atmospheric Plasma (NTAP). This minimally invasive procedure selectively destroys cancer cells without damaging the surrounding healthy tissue. Clinically tested ,working towards commercialization. Visit website.

    CAPS Medical

    Presenter

    arrow
    Ilan Uchitel

    CEO & Co-Founder

    CAPS Medical is developing a solution to treat a wide range of solid tumors using Non-thermal Atmospheric Plasma (NTAP). This minimally invasive procedure selectively destroys cancer cells without damaging the surrounding healthy tissue. Clinically tested ,working towards commercialization. Visit website.

  • Portal Instruments

    Presenter

    arrow
    Patrick Anquetil

    CEO

    Portal Instruments is developing a needle-free technology for the delivery of biologics. The handheld device is capable of delivering small and large molecules through subcutaneous, intradermal and intramuscular tissue layers. Portal's technology will improve the patient experience, providing greater comfort during drug administration. Visit website.

    Portal Instruments

    Presenter

    arrow
    Patrick Anquetil

    CEO

    Portal Instruments is developing a needle-free technology for the delivery of biologics. The handheld device is capable of delivering small and large molecules through subcutaneous, intradermal and intramuscular tissue layers. Portal's technology will improve the patient experience, providing greater comfort during drug administration. Visit website.

  • Isola Therapeutics

    Presenter

    Isola Therapeutics is committed to developing more effective and accessible treatments to address the increasing burden of cancer. The company is developing a local drug delivery system that delivers chemotherapeutic payloads to solid tumors, while reducing systemic complications often associated with traditional chemotherapy regimens.  Visit website.

    Isola Therapeutics

    Presenter

    Isola Therapeutics is committed to developing more effective and accessible treatments to address the increasing burden of cancer. The company is developing a local drug delivery system that delivers chemotherapeutic payloads to solid tumors, while reducing systemic complications often associated with traditional chemotherapy regimens.  Visit website.

  • Navigation Sciences

    Presenter

    arrow
    Alan Lucas

    CEO

    Navigation Sciences™ is a clinical-stage company developing the NaviSci™ System for the tissue conserving removal of lung cancer and other soft tissue tumors. The system integrates Augmented Reality (AR) and advanced software with surgical hardware to guide precise surgical resection by enabling for the first time, real-time in-vivo margin measurement. Visit website.

    Navigation Sciences

    Presenter

    arrow
    Alan Lucas

    CEO

    Navigation Sciences™ is a clinical-stage company developing the NaviSci™ System for the tissue conserving removal of lung cancer and other soft tissue tumors. The system integrates Augmented Reality (AR) and advanced software with surgical hardware to guide precise surgical resection by enabling for the first time, real-time in-vivo margin measurement. Visit website.

  • Bionic Vision Technologies

    Presenter

    arrow
    Ash Attia

    CEO

    BVT Bionic Eye System is a suprachoroidal visual implant that has been designed to restore functional vision to the blind suffering from inherited retinal diseases. The Bionic Eye System consists of a retinal implant that receives visual images that are captured, processed, and transferred via a wearable device and processing unit.  Visit website.

    Bionic Vision Technologies

    Presenter

    arrow
    Ash Attia

    CEO

    BVT Bionic Eye System is a suprachoroidal visual implant that has been designed to restore functional vision to the blind suffering from inherited retinal diseases. The Bionic Eye System consists of a retinal implant that receives visual images that are captured, processed, and transferred via a wearable device and processing unit.  Visit website.

  • SentiAR

    Presenter

    arrow
    Berk Tas

    CEO

    Transforming the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient. Visit website.

    SentiAR

    Presenter

    arrow
    Berk Tas

    CEO

    Transforming the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient. Visit website.

  • LEM Surgical

    Presenter

    arrow
    Yossi Bar

    CEO

    LEM Surgical is focused on creating and providing the next generation of robotic surgical systems. The company's flagship product, the Dynamis System, is a multi-arm robotic surgical system that incorporates novel navigation capabilities and has an open architecture for handling concentric tools. Dynamis is intended to be a platform technology for orthopedic and neurosurgical applications. Visit website.

    LEM Surgical

    Presenter

    arrow
    Yossi Bar

    CEO

    LEM Surgical is focused on creating and providing the next generation of robotic surgical systems. The company's flagship product, the Dynamis System, is a multi-arm robotic surgical system that incorporates novel navigation capabilities and has an open architecture for handling concentric tools. Dynamis is intended to be a platform technology for orthopedic and neurosurgical applications. Visit website.

  • Field Orthopaedics

    Presenter

    arrow
    Patryk Kania

    CEO and President

    Field Orthopaedics is dedicated to developing innovative products to meet the needs of complex fracture management, arthritis and microsurgery. The company's portfolio of cannulated screws and intramedullary nailing system address the challenges critical to advancing hand surgery. Visit website.

    Field Orthopaedics

    Presenter

    arrow
    Patryk Kania

    CEO and President

    Field Orthopaedics is dedicated to developing innovative products to meet the needs of complex fracture management, arthritis and microsurgery. The company's portfolio of cannulated screws and intramedullary nailing system address the challenges critical to advancing hand surgery. Visit website.

  • Juniper Biomedical

    Presenter

    arrow
    David Constantine

    CEO

    Juniper Biomedical is developing a precision neuromodulation micro-implant to treat pelvic health conditions. Visit website.

    Juniper Biomedical

    Presenter

    arrow
    David Constantine

    CEO

    Juniper Biomedical is developing a precision neuromodulation micro-implant to treat pelvic health conditions. Visit website.

  • Ossiform

    Presenter

    arrow
    Thea Wulff Olesen

    CEO

    Ossiform is the developer of fully resorbable patient-matched implants, tailored to improve bone healing outcomes in orthopedics and spine. According to Ossiform: We Print Bone™. Visit website.

    Ossiform

    Presenter

    arrow
    Thea Wulff Olesen

    CEO

    Ossiform is the developer of fully resorbable patient-matched implants, tailored to improve bone healing outcomes in orthopedics and spine. According to Ossiform: We Print Bone™. Visit website.

  • Runway Healthcare

    Presenter

    arrow
    Jeffrey O'Donnell, Jr.

    CEO

    Runway Healthcare is a medical device venture studio helping bring innovative, early-stage technologies to market in partnership with entrepreneurial doctors, professionals, and businesses. The company's portfolio currently consists of multiple orthopedic-focused businesses dedicated to enabling physicians and improving patient care. Visit website.

    Runway Healthcare

    Presenter

    arrow
    Jeffrey O'Donnell, Jr.

    CEO

    Runway Healthcare is a medical device venture studio helping bring innovative, early-stage technologies to market in partnership with entrepreneurial doctors, professionals, and businesses. The company's portfolio currently consists of multiple orthopedic-focused businesses dedicated to enabling physicians and improving patient care. Visit website.

  • CDX Medical Technologies

    Presenter

    arrow
    Gopal K. Chopra

    Co-CEO

    CDX is a compact portable extracorporeal bypass pump for partial cardio-pulmonary support, adaptable to multiple circuit configurations including oxygenators. CDX's technology is an innovative, light-weight support system with multiple power options. The CDX pump platform is a disposable cartridge combined with a re-useable controller and stator. The entire system is less than 6 pounds in weight and can be primed and ready to support in less than 2 minutes. visit website

    CDX Medical Technologies

    Presenter

    arrow
    Gopal K. Chopra

    Co-CEO

    CDX is a compact portable extracorporeal bypass pump for partial cardio-pulmonary support, adaptable to multiple circuit configurations including oxygenators. CDX's technology is an innovative, light-weight support system with multiple power options. The CDX pump platform is a disposable cartridge combined with a re-useable controller and stator. The entire system is less than 6 pounds in weight and can be primed and ready to support in less than 2 minutes. visit website

  • Novian Health

    Presenter

    arrow
    Henry (Chip) Appelbaum

    President & CEO

    Novian Health has developed a laser-based system for the treatment of tumors. The technology is intended to be a minimally invasive alternative to surgery in select cancerous and non-cancerous tumors. Novian has received the CE Mark for the treatment of malignant and benign breast tumors. The company's Novilase technology is currently cleared in the US for the treatment of benign breast tumors and soft tissue ablation. Visit website.

    Novian Health

    Presenter

    arrow
    Henry (Chip) Appelbaum

    President & CEO

    Novian Health has developed a laser-based system for the treatment of tumors. The technology is intended to be a minimally invasive alternative to surgery in select cancerous and non-cancerous tumors. Novian has received the CE Mark for the treatment of malignant and benign breast tumors. The company's Novilase technology is currently cleared in the US for the treatment of benign breast tumors and soft tissue ablation. Visit website.

  • SamanTree Medical

    Presenter

    arrow
    Olivier Delporte

    CEO

    SamanTree Medical's Histolog Scanner is a digital microscopy scanner for high-resolution imaging of the surface of fresh tissue. The device utilizes novel, ultra-fast confocal microscopy technology to enable rapid histological assessment in the operating room or pathology laboratory.  Visit website.

    SamanTree Medical

    Presenter

    arrow
    Olivier Delporte

    CEO

    SamanTree Medical's Histolog Scanner is a digital microscopy scanner for high-resolution imaging of the surface of fresh tissue. The device utilizes novel, ultra-fast confocal microscopy technology to enable rapid histological assessment in the operating room or pathology laboratory.  Visit website.

  • Agada Medical

    Presenter

    arrow
    Scott Gunnigle

    CEO

    Agada Medical is innovating in the field of spine surgery through their development of an Enterprise AI system named THE SPINE ORACLE™. This system aims to revolutionize spine surgery planning by using anthropometric, demographic, diagnostic data, and biomechanical models to predict surgical outcomes and costs. It leverages AI to analyze spine motion, surgical simulations and force distributions, offering prescriptive and predictive analytics to reduce unnecessary surgeries by comparing various surgical options. Visit website.

    Agada Medical

    Presenter

    arrow
    Scott Gunnigle

    CEO

    Agada Medical is innovating in the field of spine surgery through their development of an Enterprise AI system named THE SPINE ORACLE™. This system aims to revolutionize spine surgery planning by using anthropometric, demographic, diagnostic data, and biomechanical models to predict surgical outcomes and costs. It leverages AI to analyze spine motion, surgical simulations and force distributions, offering prescriptive and predictive analytics to reduce unnecessary surgeries by comparing various surgical options. Visit website.

  • Brain4Care

    Presenter

    arrow
    Carlos Bremer

    President North American Division

    Brain4care offers an FDA-cleared and non-invasive Intracranial Pressure (ICP) dynamics monitoring technology, eliminating the invasiveness of the current gold standard and unlocking its applicability for patients with brain damage, beyond the ICU. By breaking down the barriers to accessibility and expanding its utility by using an AI platform, the company aims to make ICP monitoring a routine and essential part of patient care anytime and anywhere. Visit website.

    Brain4Care

    Presenter

    arrow
    Carlos Bremer

    President North American Division

    Brain4care offers an FDA-cleared and non-invasive Intracranial Pressure (ICP) dynamics monitoring technology, eliminating the invasiveness of the current gold standard and unlocking its applicability for patients with brain damage, beyond the ICU. By breaking down the barriers to accessibility and expanding its utility by using an AI platform, the company aims to make ICP monitoring a routine and essential part of patient care anytime and anywhere. Visit website.

  • Spiro Roboitcs

    Presenter

    arrow
    Dimitri Sokolov

    CEO

    Spiro Robotics is developing an innovative handheld robot intended to automate airway management in patients requiring tracheal intubation.  Visit website.

    Spiro Roboitcs

    Presenter

    arrow
    Dimitri Sokolov

    CEO

    Spiro Robotics is developing an innovative handheld robot intended to automate airway management in patients requiring tracheal intubation.  Visit website.

  • Adaptyx Biosceinces

    Presenter

    arrow
    Vijit Sabnis

    Co-Founder

    Adaptyx Biosciences, a Stanford University spin-off, is building a biomonitoring platform that leverages 15 years of research in molecular switches and microarray patches, enabling minimally-invasive real-time, continuous sensing of small molecules and proteins. Adaptyx's library of multi-analyte sensors will enable deeply personalized medicine across drug dosing, hormone regulation, kidney health, cardiovascular disease, and oncology.

    Adaptyx Biosceinces

    Presenter

    arrow
    Vijit Sabnis

    Co-Founder

    Adaptyx Biosciences, a Stanford University spin-off, is building a biomonitoring platform that leverages 15 years of research in molecular switches and microarray patches, enabling minimally-invasive real-time, continuous sensing of small molecules and proteins. Adaptyx's library of multi-analyte sensors will enable deeply personalized medicine across drug dosing, hormone regulation, kidney health, cardiovascular disease, and oncology.

  • Alara Med

    Presenter

    arrow
    Mark Salley

    CEO

    The cumulative exposure to ionizing radiation during medical procedures poses serious health risks to patients, surgical staff, and surgeons. AlaraMed is rethinking radiation safety with a portfolio of products designed to reduce unnecessary radiation exposure. The company’s lead product is a device for endoscopic kidney surgery and other fluoroscopy procedures that reduces fluoroscopy time by ~80%.  Visit website.

    Alara Med

    Presenter

    arrow
    Mark Salley

    CEO

    The cumulative exposure to ionizing radiation during medical procedures poses serious health risks to patients, surgical staff, and surgeons. AlaraMed is rethinking radiation safety with a portfolio of products designed to reduce unnecessary radiation exposure. The company’s lead product is a device for endoscopic kidney surgery and other fluoroscopy procedures that reduces fluoroscopy time by ~80%.  Visit website.

  • Aulisa Medical

    Presenter

    arrow
    Augustine Lien

    CEO

    Aulisa specializes in the development and commercialization of wearable solutions for continuous remote monitoring of patient vitals. The company's proprietary technology continuously monitors vital signs to identify health incidents prior to them occurring. Rapid spot-checking of patient vitals allows the device to alert providers and parents to health incidents, expanding the window in which appropriate treatment and care can be delivered. The company's flagship product, the Guardian Angel RX system, has been adapted for use in infants, children, and adults. Visit website.

    Aulisa Medical

    Presenter

    arrow
    Augustine Lien

    CEO

    Aulisa specializes in the development and commercialization of wearable solutions for continuous remote monitoring of patient vitals. The company's proprietary technology continuously monitors vital signs to identify health incidents prior to them occurring. Rapid spot-checking of patient vitals allows the device to alert providers and parents to health incidents, expanding the window in which appropriate treatment and care can be delivered. The company's flagship product, the Guardian Angel RX system, has been adapted for use in infants, children, and adults. Visit website.

  • Axena Health

    Presenter

    arrow
    Eileen Maus

    CEO

    Axena Health is dedicated to improving the lives of women with pelvic floor disorders. The company's Leva Pelvic Health system helps women train and strengthen their pelvic floor muscles from their homes to improve the management of stress, mixed, and mild-to-moderate urinary incontinence and chronic fecal incontinence.  Visit website.

    Axena Health

    Presenter

    arrow
    Eileen Maus

    CEO

    Axena Health is dedicated to improving the lives of women with pelvic floor disorders. The company's Leva Pelvic Health system helps women train and strengthen their pelvic floor muscles from their homes to improve the management of stress, mixed, and mild-to-moderate urinary incontinence and chronic fecal incontinence.  Visit website.

  • Azra Care

    Presenter

    arrow
    Christian Pean

    CEO

    Azra Care is a healthcare technology company specializing in integrating SaaS AI solutions into orthopedic care to enhance patient outcomes and operational efficiency. The company’s platform leverages advanced analytics and machine learning to support evidence-based, equity-focused clinical decision-making and population health management. Azra Care is committed to transforming orthopedic surgery and care delivery through innovative, value-based approaches that address racial disparities and improve healthcare access for all. Visit website.

    Azra Care

    Presenter

    arrow
    Christian Pean

    CEO

    Azra Care is a healthcare technology company specializing in integrating SaaS AI solutions into orthopedic care to enhance patient outcomes and operational efficiency. The company’s platform leverages advanced analytics and machine learning to support evidence-based, equity-focused clinical decision-making and population health management. Azra Care is committed to transforming orthopedic surgery and care delivery through innovative, value-based approaches that address racial disparities and improve healthcare access for all. Visit website.

  • Bimini Health Tech

    Presenter

    arrow
    Bradford Conlan

    CEO

    Bimini Healthtech is developing a diverse portfolio of regenerative technologies and therapeutics that enable people to live better lives. The company is commercializing and investigating autologous and allogenic products and therapies intended for use at the point-of-care to eliminate the need for matching patients with donors.  Visit website.

    Bimini Health Tech

    Presenter

    arrow
    Bradford Conlan

    CEO

    Bimini Healthtech is developing a diverse portfolio of regenerative technologies and therapeutics that enable people to live better lives. The company is commercializing and investigating autologous and allogenic products and therapies intended for use at the point-of-care to eliminate the need for matching patients with donors.  Visit website.

  • CairnSurgical

    Presenter

    arrow
    David Danielsen

    CEO

    CairnSurgical is developing an innovative tool to guide surgical interventions in patients with cancer. The company's Breast Cancer Locator (BCL) is a proprietary, patient-specific, 3D printed surgical guide intended to reduce positive margins during breast cancer tumor removal. The solution uses MRI data to create a personalized model that assist surgeons in localization and excision of tumors to reduce positive margins. Visit website.

    CairnSurgical

    Presenter

    arrow
    David Danielsen

    CEO

    CairnSurgical is developing an innovative tool to guide surgical interventions in patients with cancer. The company's Breast Cancer Locator (BCL) is a proprietary, patient-specific, 3D printed surgical guide intended to reduce positive margins during breast cancer tumor removal. The solution uses MRI data to create a personalized model that assist surgeons in localization and excision of tumors to reduce positive margins. Visit website.

  • Neuronoff

    Presenter

    arrow
    Manfred Franke

    CEO

    Neuronoff is developing an injectable electrode platform that is an adaptive, minimally invasive technology that transforms complex neuromodulation procedures into simple outpatient procedures. The Injectrode technology enables the electrical stimulation of hard to reach nerves and tissues using an 18 ga needle and self-anchor to prevent lead migration. Visit website.

    Neuronoff

    Presenter

    arrow
    Manfred Franke

    CEO

    Neuronoff is developing an injectable electrode platform that is an adaptive, minimally invasive technology that transforms complex neuromodulation procedures into simple outpatient procedures. The Injectrode technology enables the electrical stimulation of hard to reach nerves and tissues using an 18 ga needle and self-anchor to prevent lead migration. Visit website.

  • ConnCons

    Presenter

    arrow
    Jochen Hampe

    CEO

    ConnCons integrates connectivity into infusion consumables to create a cloud to vessel end-to-end digital solution. The system enables safer, faster and automated therapies with a superior patient experience. First clinical applications are targeted at both center-based and home oncological therapy. Visit website.

    ConnCons

    Presenter

    arrow
    Jochen Hampe

    CEO

    ConnCons integrates connectivity into infusion consumables to create a cloud to vessel end-to-end digital solution. The system enables safer, faster and automated therapies with a superior patient experience. First clinical applications are targeted at both center-based and home oncological therapy. Visit website.

  • LifeSignals

    Presenter

    arrow
    Surendar Magar

    CEO

    Supporting the development of wearable microsensors for the measuresment of biometric signals. LifeSignals works with companies to develop health and wellness monitoring solutions with their portfolio of patented hardware and software. Visit website.

    LifeSignals

    Presenter

    arrow
    Surendar Magar

    CEO

    Supporting the development of wearable microsensors for the measuresment of biometric signals. LifeSignals works with companies to develop health and wellness monitoring solutions with their portfolio of patented hardware and software. Visit website.

  • Linshom Medical

    Presenter

    arrow
    Richard Hughen

    CEO

    Linshom (“to breathe”) is first to deliver an Operating Room quality respiratory profile to the patient bedside and home for continuous, predictive respiratory monitoring (CPRM). Our FDA cleared device provides a full respiratory profile delivered continuously and in real time to predict and intercept respiratory decline before an emergency develops. Visit website.

    Linshom Medical

    Presenter

    arrow
    Richard Hughen

    CEO

    Linshom (“to breathe”) is first to deliver an Operating Room quality respiratory profile to the patient bedside and home for continuous, predictive respiratory monitoring (CPRM). Our FDA cleared device provides a full respiratory profile delivered continuously and in real time to predict and intercept respiratory decline before an emergency develops. Visit website.

  • Medfiniti

    Presenter

    arrow
    Michael Goeree

    Founder & Chairman

    Medfiniti is focused on specialized medtech solutions to market through expertise in business strategy and M&A. It's lead portfolio company, HemWell MD, is pioneering an electrosurgical procedure for the treatment of symptomatic hemorrhoids. Performed in an outpatient setting, the device ligates hemorrhoids to provide rapid relief to patients in less.  Visit website.

    Medfiniti

    Presenter

    arrow
    Michael Goeree

    Founder & Chairman

    Medfiniti is focused on specialized medtech solutions to market through expertise in business strategy and M&A. It's lead portfolio company, HemWell MD, is pioneering an electrosurgical procedure for the treatment of symptomatic hemorrhoids. Performed in an outpatient setting, the device ligates hemorrhoids to provide rapid relief to patients in less.  Visit website.

  • Neuroelectrics

    Presenter

    arrow
    Ana Maiques

    CEO

    Diagnostic and treatment telemedicine wireless platforms based on Starstim and Enobio, combining multichannel transcranial current stimulation such as tDCS with EEG. Visit website.

    Neuroelectrics

    Presenter

    arrow
    Ana Maiques

    CEO

    Diagnostic and treatment telemedicine wireless platforms based on Starstim and Enobio, combining multichannel transcranial current stimulation such as tDCS with EEG. Visit website.

  • Osteal Therapeutics

    Presenter

    arrow
    David Thompson

    CEO

    Osteal Therapeutics is a musculoskeletal therapeutics company developing solutions for the treatment of orthopedic infections. The company's lead product, VT-X7, is a drug-device combination that utilizes high concentrations of vancomycin and tobramycin, in conjunction with a drug delivery system, to irrigate infected joint spaces as a result of periprosthetic joint infection in joint replacement patients.  Visit website.

    Osteal Therapeutics

    Presenter

    arrow
    David Thompson

    CEO

    Osteal Therapeutics is a musculoskeletal therapeutics company developing solutions for the treatment of orthopedic infections. The company's lead product, VT-X7, is a drug-device combination that utilizes high concentrations of vancomycin and tobramycin, in conjunction with a drug delivery system, to irrigate infected joint spaces as a result of periprosthetic joint infection in joint replacement patients.  Visit website.

  • PercuSense

    Presenter

    arrow
    Brian Kannard

    Founder

    PercuSense’s continuous multi-analyte sensor system combines monitoring of multiple biosensors with knowledge of how diseases and illness progress to intelligently and proactively recommend treatment. Visit website.

    PercuSense

    Presenter

    arrow
    Brian Kannard

    Founder

    PercuSense’s continuous multi-analyte sensor system combines monitoring of multiple biosensors with knowledge of how diseases and illness progress to intelligently and proactively recommend treatment. Visit website.

  • Sana Health

    Presenter

    arrow
    Richard Hanbury

    CEO

    Non-invasive bio-therapeutic device for pain management. Visit website.

    Sana Health

    Presenter

    arrow
    Richard Hanbury

    CEO

    Non-invasive bio-therapeutic device for pain management. Visit website.

  • Sonofii

    Presenter

    arrow
    Roberta Lee

    CEO

    Sonofii has developed a Dynamic Dual Therapy to treat intractable soft tissue infections. The company's first clinical trial had an 80% success in curing infections that failed conventional therapy. In this multi billion dollar market, Sonofii is poised to advance treatment, improve patients’ lives and significantly reduce costs to the health care system. Visit website.

    Sonofii

    Presenter

    arrow
    Roberta Lee

    CEO

    Sonofii has developed a Dynamic Dual Therapy to treat intractable soft tissue infections. The company's first clinical trial had an 80% success in curing infections that failed conventional therapy. In this multi billion dollar market, Sonofii is poised to advance treatment, improve patients’ lives and significantly reduce costs to the health care system. Visit website.

  • Arsenal Medical

    Presenter

    arrow
    Upma Sharma

    President & CEO

    Arsenal Medical develops purpose-built biomaterials to solve challenging and underserved medical problems. Our lead products target neurovascular and trauma conditions providing control of blood flow to tumors and hemorrhage.  Visit website.

    Arsenal Medical

    Presenter

    arrow
    Upma Sharma

    President & CEO

    Arsenal Medical develops purpose-built biomaterials to solve challenging and underserved medical problems. Our lead products target neurovascular and trauma conditions providing control of blood flow to tumors and hemorrhage.  Visit website.

  • Vektor Medical

    Presenter

    Vektor Medical is on a mission to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias. Through its AI-based, non-invasive arrhythmia analysis technology, vMap, the company aims to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency. Visite website.

    Vektor Medical

    Presenter

    Vektor Medical is on a mission to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias. Through its AI-based, non-invasive arrhythmia analysis technology, vMap, the company aims to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency. Visite website.

  • Restera

    Presenter

    arrow
    Rick O'Connor

    CEO

    Restera is developing an outpatient injectable stimulation solution for all obstructive sleep apnea (OSA) indications. The company's disruptive, injectable, dual-target stimulation solution offers immediate and unrivaled therapy. Their landmark published therapy won the 2024 best abstract award. Founded by serial entrepreneurs with multiple exits. Visit website.

    Restera

    Presenter

    arrow
    Rick O'Connor

    CEO

    Restera is developing an outpatient injectable stimulation solution for all obstructive sleep apnea (OSA) indications. The company's disruptive, injectable, dual-target stimulation solution offers immediate and unrivaled therapy. Their landmark published therapy won the 2024 best abstract award. Founded by serial entrepreneurs with multiple exits. Visit website.

  • THINK Surgical

    Presenter

    arrow
    Stuart Simpson

    CEO

    THINK Surgical develops and commercializes robotic surgery systems for the orthopedics market. The company's TSolution One is indicated for total knee arthroplasty. The system is capable of fully automated bone preparation that is personalized and prepared utilizing proprietary planning tools to achieve optimal fit of the selected knee implant. Visit website.

    THINK Surgical

    Presenter

    arrow
    Stuart Simpson

    CEO

    THINK Surgical develops and commercializes robotic surgery systems for the orthopedics market. The company's TSolution One is indicated for total knee arthroplasty. The system is capable of fully automated bone preparation that is personalized and prepared utilizing proprietary planning tools to achieve optimal fit of the selected knee implant. Visit website.

  • Nutromics

    Presenter

    arrow
    Peter Vranes

    CEO

    Nutromics is pioneering Continuous Molecular Monitoring (CMM), a real-time biomarker monitoring platform that offers molecular patient data. The technology integrates into a wearable smart patch that continuously captures and transmits data to mobile and web-based applications for easy integration with hospital and consumer health software.  Visit website.

    Nutromics

    Presenter

    arrow
    Peter Vranes

    CEO

    Nutromics is pioneering Continuous Molecular Monitoring (CMM), a real-time biomarker monitoring platform that offers molecular patient data. The technology integrates into a wearable smart patch that continuously captures and transmits data to mobile and web-based applications for easy integration with hospital and consumer health software.  Visit website.

  • Sparta Biomedical

    Presenter

    arrow
    Dimitrios Angelis

    Co-Founder

    The first osseointegrative biomimetic knee cartilage implant. Visit website.

    Sparta Biomedical

    Presenter

    arrow
    Dimitrios Angelis

    Co-Founder

    The first osseointegrative biomimetic knee cartilage implant. Visit website.

  • Flow Medical

    Presenter

    arrow
    Jennifer Fried

    CEO

    Flow Medical is developing a novel thrombolytic catheter for the treatment of pulmonary embolism. The device will combine imaging, infusion, and monitoring into a single solution to streamline procedures, improve therapeutic efficacy, and reduce inventory needs. Visit website.

    Flow Medical

    Presenter

    arrow
    Jennifer Fried

    CEO

    Flow Medical is developing a novel thrombolytic catheter for the treatment of pulmonary embolism. The device will combine imaging, infusion, and monitoring into a single solution to streamline procedures, improve therapeutic efficacy, and reduce inventory needs. Visit website.

  • PhotoniCare

    Presenter

    arrow
    Cary Vance

    CEO

    The OtoSight Middle Ear Scope enables clinicians to quickly and easily see directly through the eardrum to directly visualize the middle ear, drastically improving care for middle ear infections, the leading cause of hearing loss, antibiotic use, and surgeries in children. The novel device has new reimbursement codes that are seeing robust payment rates. Visit website.

    PhotoniCare

    Presenter

    arrow
    Cary Vance

    CEO

    The OtoSight Middle Ear Scope enables clinicians to quickly and easily see directly through the eardrum to directly visualize the middle ear, drastically improving care for middle ear infections, the leading cause of hearing loss, antibiotic use, and surgeries in children. The novel device has new reimbursement codes that are seeing robust payment rates. Visit website.

  • Pulnovo Medical

    Presenter

    arrow
    Erika Chen

    Business Development Lead

    Pulnovo Medical is developing radiofrequency (RF) solutions for the treatment of pulmonary hypertension. PADN is a multipolar synchronous pulmonary artery RF ablation catheter that is intended to treat pulmonary hypertension by ablating the sympathetic nerve at the target site. The device is capable of point-to-point ablation of pulmonary sympathetic nerves. Visit website.

    Pulnovo Medical

    Presenter

    arrow
    Erika Chen

    Business Development Lead

    Pulnovo Medical is developing radiofrequency (RF) solutions for the treatment of pulmonary hypertension. PADN is a multipolar synchronous pulmonary artery RF ablation catheter that is intended to treat pulmonary hypertension by ablating the sympathetic nerve at the target site. The device is capable of point-to-point ablation of pulmonary sympathetic nerves. Visit website.

  • Navigate Maternity

    Presenter

    arrow
    Ariana McGee

    Founder & Chief Executive Officer

    Navigate Maternity is a tech-enabled medical device company dedicated to improving maternal health. Their system enhances care coordination through remote monitoring, capturing key biometric data from the first prenatal appointment to twelve months postpartum via a mobile app and Bluetooth devices. The app also provides validated questionnaires for better clinical decision-making. Visit website.

    Navigate Maternity

    Presenter

    arrow
    Ariana McGee

    Founder & Chief Executive Officer

    Navigate Maternity is a tech-enabled medical device company dedicated to improving maternal health. Their system enhances care coordination through remote monitoring, capturing key biometric data from the first prenatal appointment to twelve months postpartum via a mobile app and Bluetooth devices. The app also provides validated questionnaires for better clinical decision-making. Visit website.

  • EP Solutions

    Presenter

    arrow
    Marcin Golebicki

    CEO

    EP Solutions is improving clinical outcomes in cardiac resynchronization therapy cases through the use of noninvasive cardiac mapping technology. The company's Amycard 01C is an electrophysiology workstation that records body surface electrograms to create optimized 3D heart models that merge ECG data with anatomical data obtained from medical imaging. EP Solutions' technology helps physicians accurately place CRT leads during implantation and optimize devices during follow-up visits. Visit website.

    EP Solutions

    Presenter

    arrow
    Marcin Golebicki

    CEO

    EP Solutions is improving clinical outcomes in cardiac resynchronization therapy cases through the use of noninvasive cardiac mapping technology. The company's Amycard 01C is an electrophysiology workstation that records body surface electrograms to create optimized 3D heart models that merge ECG data with anatomical data obtained from medical imaging. EP Solutions' technology helps physicians accurately place CRT leads during implantation and optimize devices during follow-up visits. Visit website.

  • Buck Surgical

    Presenter

    arrow
    Donald Buck

    CEO

    Buck Surgical is dedicated to addressing the challenges of gastrointestinal, microvascular, and vascular surgery with its patented coupling technology. The company has developed a novel and efficient solution that rapidly creates a connection (anastomoses) to provide unobstructed flow. Visit website.

    Buck Surgical

    Presenter

    arrow
    Donald Buck

    CEO

    Buck Surgical is dedicated to addressing the challenges of gastrointestinal, microvascular, and vascular surgery with its patented coupling technology. The company has developed a novel and efficient solution that rapidly creates a connection (anastomoses) to provide unobstructed flow. Visit website.

  • Joint Preservation Innovations

    Presenter

    arrow
    Sanjeev Bhatia

    CEO

    Joint Preservation Innovations (JPI) is proud to present the Articulator Bone Resector, a novel arthroscopic articulating bone resection tool. Developed over 7 years with input from leading surgeons along with automotive, aerospace and medical device engineers, Articulator gives minimally invasive surgeons the freedom to finally articulate rotary cutting tools for bone resection in a manner never before possible. Awarded an FDA Breakthrough Device Designation in 2023, Articulator aims to reduce the surgical footprint of various musculoskeletal procedures, including large market applications in arthroscopic, endoscopic spinal and robotic surgery. Visit website.

    Joint Preservation Innovations

    Presenter

    arrow
    Sanjeev Bhatia

    CEO

    Joint Preservation Innovations (JPI) is proud to present the Articulator Bone Resector, a novel arthroscopic articulating bone resection tool. Developed over 7 years with input from leading surgeons along with automotive, aerospace and medical device engineers, Articulator gives minimally invasive surgeons the freedom to finally articulate rotary cutting tools for bone resection in a manner never before possible. Awarded an FDA Breakthrough Device Designation in 2023, Articulator aims to reduce the surgical footprint of various musculoskeletal procedures, including large market applications in arthroscopic, endoscopic spinal and robotic surgery. Visit website.

  • Satisfai Health

    Presenter

    arrow
    Solveig Johannessen

    CEO

    Satisfai Health is a software company focusing on computer vision AI for gastroenterology, across both endoscopic and ultrasound imaging. Our products are used by pharmaceutical companies and healthcare providers to digitally assess important, life-altering conditions, including Inflammatory Bowel Disease and pre-Esophageal Cancer. Visit website.

    Satisfai Health

    Presenter

    arrow
    Solveig Johannessen

    CEO

    Satisfai Health is a software company focusing on computer vision AI for gastroenterology, across both endoscopic and ultrasound imaging. Our products are used by pharmaceutical companies and healthcare providers to digitally assess important, life-altering conditions, including Inflammatory Bowel Disease and pre-Esophageal Cancer. Visit website.

  • CAPS Medical

    Presenter

    arrow
    Ilan Uchitel

    CEO & Co-Founder

    CAPS Medical is developing a solution to treat a wide range of solid tumors using Non-thermal Atmospheric Plasma (NTAP). This minimally invasive procedure selectively destroys cancer cells without damaging the surrounding healthy tissue. Clinically tested ,working towards commercialization. Visit website.

    CAPS Medical

    Presenter

    arrow
    Ilan Uchitel

    CEO & Co-Founder

    CAPS Medical is developing a solution to treat a wide range of solid tumors using Non-thermal Atmospheric Plasma (NTAP). This minimally invasive procedure selectively destroys cancer cells without damaging the surrounding healthy tissue. Clinically tested ,working towards commercialization. Visit website.

What is LSI USA ‘25?
Authentic panels and keynotes with the leaders in Medtech
Date TBD
Keynote with Lisa Earnhardt, Executive Vice President & Group President, Medical Devices at Abbott
Date TBD
Advancing Neuromodulation Therapy for Mixed Urinary Incontinence and Investing in Amber Therapeutics
Date TBD
Medtech Market and Venture Investment Outlook:
State of Seed and Growth in 2025
Date TBD
What Matters to Corporate VCs in 2025?
Date TBD
Human and Financial Capital: How Winning Management Teams Hire, Develop, and Retain Talent to Scale
Want to Speak on a Panel
With Other Leaders?
Register arrow
March 18th - 22nd, 2025
Waldorf Astoria | Monarch Beach Resort
gallery
gallery
gallery
gallery
gallery
gallery
gallery
gallery
gallery
gallery
gallery
gallery

Sponsorship opportunities

Elevate your brand and
accelerate growth at the
epicenter of the industry

resort
resort
resort
resort

Location Information

Rooms are available from March 1 7-22 with a three night minimum.

Waldorf Astoria Monarch Beach Resort

The LSI room block is now open and a limited number of rooms are available at a special rate. The room block sells out early every year. Please do not wait to book your room.

resort
resort
resort
resort
resort icon
Special LSI Rates Available

Hear what industry leaders think

Resources from the LSI
Alumni

Our resource library contains thousands of insightful executive
sessions from previous events, captivating photos, and the latest
alumni news. Dive in today to prepare for your next LSI experience.

Activities

Unwind and connect with fellow
executives during our social day
Monarch Beach Golf Links

Named one of Golf Digest’s “Best Places to Play” and a GOLF Magazine “Gold Medal Resort.”

Waldorf Astoria Spa

Immerse yourself in the Waldorf Astoria Spa, and usher yourself into moments of optimal living.

Restorative Coastal Walk

Discover breathtaking views of the Pacific with a guided beach hike along bluffs.

Yoga

Improve the health and function of both body and mind with some Yoga or Pilates.

  • Monarch Beach Golf Links

    Named one of Golf Digest’s “Best Places to Play” and a GOLF Magazine “Gold Medal Resort.”

  • Waldorf Astoria Spa

    Immerse yourself in the Waldorf Astoria Spa, and usher yourself into moments of optimal living.

  • Restorative Coastal Walk

    Discover breathtaking views of the Pacific with a guided beach hike along bluffs.

  • Yoga

    Improve the health and function of both body and mind with some Yoga or Pilates.

Partnering will soon
open for all registered
attendees

Register below to start building your profile in the app.

playstore appstore

Have Questions?
Visit Our FAQ For
More Assistance

Visit FAQ Page arrow

Work with us

Accelerate
your
business

We’re here to help you make smarter decisions
and form stronger partnerships through curated events,
independent market intelligence products and
services, and digital-forward media.